Navigation Links
Pharmaceutical Market India: A Comprehensive Industry Analysis
Date:9/24/2013

rapeutic Area Sales 2012 135

Exhibit 6.185: Sun Pharmaceuticals Top Ten Branded Generics in India 135

Exhibit 6.186: Sun Pharmaceuticals Number of Drug Approvals by Therapeutic Area 136

Exhibit 6.187: Zydus Research Centre Speciality Areas of Research 137

Exhibit 6.188: Zydus Cadila Vaccine R&D Areas of Research 137

Exhibit 6.189: Zydus Cadila Global 'Beyond the Billion' Business Development Strategy 138

Exhibit 6.190: Zydus Cadila Top Formulation Brands in the Indian Market 138

Exhibit 6.191: Zydus Cadila New Molecular Entities in Development Pipeline 139

Exhibit 6.192: Zydus Cadila Biosimilar Therapeutics in Development Pipeline 139

Exhibit 6.193: Zydus Cadila Indian Formulation Market Distribution (%) by Therapeutic Area 2012 140

Exhibit 6.194: Zydus Cadila Gross Sales 2006-2012 141

Exhibit 6.195: Zydus Cadila List of Subsidiary Companies 141

Exhibit 6.196: Zydus Cadila Key Acquisitions 1995-2012 142

Exhibit 6.197: Zydus Cadila Research and Development Areas of Interest 142

Exhibit 7.1: Main Growth Factors of the Indian Pharmaceutical Market 143

Exhibit 7.2: Indian Health Insurance Coverage Statistics 2010-2020 143

Exhibit 7.3: Strengths of the Indian Pharmaceutical Market 144

Exhibit 7.4: Weaknesses of the Indian Pharmaceutical Market 144

Exhibit 7.5: Opportunities within the Indian Pharmaceutical Market 145

Exhibit 7.6: Threats to the Indian Pharmaceutical Market 147

Exhibit 8.1: Aurobindo Pharma Key Contact Details 148

Exhibit 8.2: Aurobindo Pharma Board of Directors and Key Personnel 148

Exhibit 8.3: Bharat Serums and Vaccines Ltd General Contact Details 149

Exhibit 8.4: Bharat Serums and Vaccines Ltd Board of Directors 149

Exhibit 8.5: Biocon Biopharmaceuticals Key Contact Details 150

Exhibit 8.6: Biocon Biopharmaceuticals Board of Directors 151

Exhi
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... SOUTH PLAINFIELD, N.J., July 30, 2015 PTC ... corporate update and reported financial results for the second ... is progressing on many fronts across the organization.  We ... largest Duchenne muscular dystrophy clinical trial ever conducted with ... W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. ...
(Date:7/30/2015)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ) ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... notice it received on May 21, 2015 from the ... was below certain of the Exchange,s continued listing standards, ... the NYSE MKT Company Guide, due to the delay ...
(Date:7/30/2015)... LAKE, N.J. , July 30, 2015 ... simultaneously in the United States , ... the FDA, EMA and MHLW, respectively) for eribulin, for ... (STS) who have received prior chemotherapy for advanced or ... based on data from a pivotal global Phase 3 ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... 24 BioTrends Research Group, Inc. recently published its ... report is based on online ... interventional radiologists and interventional nephrologists). It provides an in-depth ... practice patterns related to both vascular access placement and ...
... Mass., Aug. 24 Echo Therapeutics, Inc. (OTC Bulletin ... needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal ... for transdermal drug delivery, today announced the completion of ... designed to evaluate the ability of Prelude to ablate ...
Cached Medicine Technology:Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market 2Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream 2Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream 3
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather Pugh earned ... care for patients at this natural health care center in Winamac. , "Oftentimes patients ... said. "Heather's role is vital to our approach because we want to focus on ...
(Date:8/1/2015)... ... August 01, 2015 , ... ... in “a trending profession” that comprises a growing percentage of U.S. physicians, and ... , That was one part of the message delivered by John W. Becher, ...
(Date:8/1/2015)... Humble, TX (PRWEB) , ... August 01, 2015 , ... ... common concern among both men and women often causing pain and discomfort. Those who ... to this circulatory problem, and Northeast Houston Vein Center is doing what it can ...
(Date:8/1/2015)... ME (PRWEB) , ... August 01, 2015 , ... Tina ... Retail Champions.” , Wilcoxson was given that honor by the National Retail Federation, the ... retail industry. Wilcoxson was one of three Maine business owners to be named as ...
(Date:8/1/2015)... and Greenwich, CT (PRWEB) , ... August 01, ... ... a Great Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical ... — incorporating it into its portfolio of state-of-the-art clinics. , “Our acquisition of ...
Breaking Medicine News(10 mins):Health News:New Patient Advocate Enhances Natural Health Care 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2
... 12, 2008) - Beta-blocker drugs may help prevent heart ... of death and major stroke, says a major study ... journal, The Lancet. , POISE is the worlds largest ... the effects of a beta-blocker versus placebo given to ...
... A.,Sandler, MD, a West Bloomfield diagnostic radiologist, was installed ... (MSMS) during,the 143rd annual meeting of the MSMS House ... of the Wayne State University School of Medicine, Doctor,Sandler ... at Henry,Ford Hospital and currently serves on the Michigan ...
... HARBIN, China, May 12 /Xinhua-PRNewswire-FirstCall/ -- China ... Yingxia" or "the,Company"), a leading provider in ... and distribution of organic nutritional food,products, supplements, ... Republic,of China ("PRC"), announced today it will ...
... hosts nine physicians from Chongqing Bureau of ... HealthPartners,Institute for Medical Education is hosting the ... to visit Minnesota. During their,three-month stay, the ... learn about health plan and hospital administration ...
... 12 Fairbank Farms, a national,ground beef producer, is ... at its Ashville, N.Y., facility and sold through Price,Chopper, ... Wholesale,distributor., The affected product may contain small pieces ... date of 05/13/08, 05/15/08, or a,"Julian date 124" on ...
... 12 PAREXEL International,Corporation (Nasdaq: PRXL ) announced ... 2008 Growth Stock Conference in Chicago, Illinois. James,Winschel, Senior ... formal presentation on PAREXEL at 10:05 a.m. EDT on ... presentation will be available through the,"Investor Relations Webcasts" section ...
Cached Medicine News:Health News:Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial 2Health News:Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial 3Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2Health News:PAREXEL International to Present at Robert W. Baird's 2008 Growth Stock Conference 2
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... Accu-Temp Cauteries provide a broad ... cauterization in a wide variety ... use cautery is packaged sterile, ... to lock switch in the ...
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... PC visual acuity system allows you access ... B-VAT II. The system includes 10 different ... testing and animated characters. Random character sequencing ... single letter, single line and multiple line ...
Medicine Products: